Remove BioTech Remove Drug Development Remove Training
article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

article thumbnail

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners.

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)

Digital Health Global

–(BUSINESS WIRE)– Aviceda Therapeutics , a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (Queen’s). CAMBRIDGE, Mass.–(BUSINESS

article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

Healthcare Professional Education: Ensuring healthcare professionals are adequately trained in the use of new technologies and treatment modalities is crucial. SolasCure: This UK-based biotech company raised £15 million to develop a wound cleaning product based on an enzyme cloned from medical maggots.

article thumbnail

How Technology Can Help Overcome Barriers to Getting Effective Therapies into Patients with Ultra Rare Disorders

Healthcare IT Today

As a physician who trained at UCSF, Harvard, and Stanford, I assumed that when my youngest daughter, Lucy – at 10-months old – was diagnosed with an ultra-rare genetic disorder of glycosylation called PGAP3, the answers would reside within a hospital or academic laboratory.

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

AI + Automation in Healthcare: Large Language Models allow researchers to train new AI models for chemistry and biology. The new year will bear witness to great innovation in biotech in the precision oncology space. Can they see changes locally in the tumor microenvironment that indicate the drug is having a biology effect?